Development of a quality-of-life measure for hidradenitis suppurativa

Mia Sisic, Joslyn S. Kirby, Sanwarjit Boyal, Lisa Plant, Chelsea McLellan, Jerry Tan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic skin disorder with adverse impacts on both physical and psychosocial well-being. There is presently no validated HS-specific quality-of-life (QoL) measure. Objective: The objective of this study is to develop a QoL instrument for HS (HS-QoL) in accordance with recommended standards. Methods: Patient interviews (concept elicitation) and expert input were used to develop the conceptual framework for outcomes perceived important to patients with HS. A HS-QoL-v1 measure was developed, and cognitive interviews with patients were conducted for pilot testing. Results: Concept elicitation interviews with patients with HS (n = 21) generated 12 themes. Most frequently reported were impacts on daily activities and symptoms due to HS. These themes, along with literature review and input from clinical experts, informed development of the HS-QoL-v1. Nine cognitive interviews were conducted in a pilot test and resulted in the HS-QoL-v2 measure. Conclusion: The HS-QoL-v2 is a preliminary QoL instrument for which further psychometric validation and establishment of clinimetric properties will be undertaken.

Original languageEnglish (US)
Pages (from-to)152-155
Number of pages4
JournalJournal of Cutaneous Medicine and Surgery
Volume21
Issue number2
DOIs
StatePublished - Jan 1 2017

Fingerprint

Hidradenitis Suppurativa
Quality of Life
Interviews
Psychometrics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Dermatology

Cite this

Sisic, Mia ; Kirby, Joslyn S. ; Boyal, Sanwarjit ; Plant, Lisa ; McLellan, Chelsea ; Tan, Jerry. / Development of a quality-of-life measure for hidradenitis suppurativa. In: Journal of Cutaneous Medicine and Surgery. 2017 ; Vol. 21, No. 2. pp. 152-155.
@article{34cfbb413eee48a6a2de39fbf2e8696f,
title = "Development of a quality-of-life measure for hidradenitis suppurativa",
abstract = "Background: Hidradenitis suppurativa (HS) is a chronic skin disorder with adverse impacts on both physical and psychosocial well-being. There is presently no validated HS-specific quality-of-life (QoL) measure. Objective: The objective of this study is to develop a QoL instrument for HS (HS-QoL) in accordance with recommended standards. Methods: Patient interviews (concept elicitation) and expert input were used to develop the conceptual framework for outcomes perceived important to patients with HS. A HS-QoL-v1 measure was developed, and cognitive interviews with patients were conducted for pilot testing. Results: Concept elicitation interviews with patients with HS (n = 21) generated 12 themes. Most frequently reported were impacts on daily activities and symptoms due to HS. These themes, along with literature review and input from clinical experts, informed development of the HS-QoL-v1. Nine cognitive interviews were conducted in a pilot test and resulted in the HS-QoL-v2 measure. Conclusion: The HS-QoL-v2 is a preliminary QoL instrument for which further psychometric validation and establishment of clinimetric properties will be undertaken.",
author = "Mia Sisic and Kirby, {Joslyn S.} and Sanwarjit Boyal and Lisa Plant and Chelsea McLellan and Jerry Tan",
year = "2017",
month = "1",
day = "1",
doi = "10.1177/1203475416677721",
language = "English (US)",
volume = "21",
pages = "152--155",
journal = "Journal of Cutaneous Medicine and Surgery",
issn = "1203-4754",
publisher = "Decker Publishing",
number = "2",

}

Development of a quality-of-life measure for hidradenitis suppurativa. / Sisic, Mia; Kirby, Joslyn S.; Boyal, Sanwarjit; Plant, Lisa; McLellan, Chelsea; Tan, Jerry.

In: Journal of Cutaneous Medicine and Surgery, Vol. 21, No. 2, 01.01.2017, p. 152-155.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development of a quality-of-life measure for hidradenitis suppurativa

AU - Sisic, Mia

AU - Kirby, Joslyn S.

AU - Boyal, Sanwarjit

AU - Plant, Lisa

AU - McLellan, Chelsea

AU - Tan, Jerry

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: Hidradenitis suppurativa (HS) is a chronic skin disorder with adverse impacts on both physical and psychosocial well-being. There is presently no validated HS-specific quality-of-life (QoL) measure. Objective: The objective of this study is to develop a QoL instrument for HS (HS-QoL) in accordance with recommended standards. Methods: Patient interviews (concept elicitation) and expert input were used to develop the conceptual framework for outcomes perceived important to patients with HS. A HS-QoL-v1 measure was developed, and cognitive interviews with patients were conducted for pilot testing. Results: Concept elicitation interviews with patients with HS (n = 21) generated 12 themes. Most frequently reported were impacts on daily activities and symptoms due to HS. These themes, along with literature review and input from clinical experts, informed development of the HS-QoL-v1. Nine cognitive interviews were conducted in a pilot test and resulted in the HS-QoL-v2 measure. Conclusion: The HS-QoL-v2 is a preliminary QoL instrument for which further psychometric validation and establishment of clinimetric properties will be undertaken.

AB - Background: Hidradenitis suppurativa (HS) is a chronic skin disorder with adverse impacts on both physical and psychosocial well-being. There is presently no validated HS-specific quality-of-life (QoL) measure. Objective: The objective of this study is to develop a QoL instrument for HS (HS-QoL) in accordance with recommended standards. Methods: Patient interviews (concept elicitation) and expert input were used to develop the conceptual framework for outcomes perceived important to patients with HS. A HS-QoL-v1 measure was developed, and cognitive interviews with patients were conducted for pilot testing. Results: Concept elicitation interviews with patients with HS (n = 21) generated 12 themes. Most frequently reported were impacts on daily activities and symptoms due to HS. These themes, along with literature review and input from clinical experts, informed development of the HS-QoL-v1. Nine cognitive interviews were conducted in a pilot test and resulted in the HS-QoL-v2 measure. Conclusion: The HS-QoL-v2 is a preliminary QoL instrument for which further psychometric validation and establishment of clinimetric properties will be undertaken.

UR - http://www.scopus.com/inward/record.url?scp=85018181983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018181983&partnerID=8YFLogxK

U2 - 10.1177/1203475416677721

DO - 10.1177/1203475416677721

M3 - Article

C2 - 27837158

AN - SCOPUS:85018181983

VL - 21

SP - 152

EP - 155

JO - Journal of Cutaneous Medicine and Surgery

JF - Journal of Cutaneous Medicine and Surgery

SN - 1203-4754

IS - 2

ER -